JP2024546946A5 - - Google Patents

Info

Publication number
JP2024546946A5
JP2024546946A5 JP2024535923A JP2024535923A JP2024546946A5 JP 2024546946 A5 JP2024546946 A5 JP 2024546946A5 JP 2024535923 A JP2024535923 A JP 2024535923A JP 2024535923 A JP2024535923 A JP 2024535923A JP 2024546946 A5 JP2024546946 A5 JP 2024546946A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
halo
heterocyclyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546946A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081521 external-priority patent/WO2023114823A1/en
Publication of JP2024546946A publication Critical patent/JP2024546946A/ja
Publication of JP2024546946A5 publication Critical patent/JP2024546946A5/ja
Pending legal-status Critical Current

Links

JP2024535923A 2021-12-15 2022-12-14 ベンゾチオフェンｒｘｆｐ１アゴニスト Pending JP2024546946A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289848P 2021-12-15 2021-12-15
US63/289,848 2021-12-15
PCT/US2022/081521 WO2023114823A1 (en) 2021-12-15 2022-12-14 Benzothiophene derivatives as rxfp1 agonists

Publications (2)

Publication Number Publication Date
JP2024546946A JP2024546946A (ja) 2024-12-26
JP2024546946A5 true JP2024546946A5 (cg-RX-API-DMAC7.html) 2025-12-22

Family

ID=85156999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535923A Pending JP2024546946A (ja) 2021-12-15 2022-12-14 ベンゾチオフェンｒｘｆｐ１アゴニスト

Country Status (5)

Country Link
EP (1) EP4448508A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024546946A (cg-RX-API-DMAC7.html)
KR (1) KR20240122834A (cg-RX-API-DMAC7.html)
CN (1) CN118647606A (cg-RX-API-DMAC7.html)
WO (1) WO2023114823A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025106780A1 (en) * 2023-11-17 2025-05-22 Eli Lilly And Company Rxfp1 receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1614676A4 (en) * 2003-03-27 2009-03-25 Kirin Pharma Kk CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF
GB0514652D0 (en) * 2005-07-15 2005-08-24 Syngenta Ltd Pesticidal mixtures
US9452973B2 (en) * 2012-05-04 2016-09-27 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Modulators of the relaxin receptor 1
EP4185381A4 (en) * 2020-07-24 2024-08-21 Inipharm, Inc. Thiophene hsd17b13 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2024540164A5 (cg-RX-API-DMAC7.html)
JP6466348B2 (ja) スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用
CA3235937A1 (en) Therapeutic compounds for hiv virus infection
AU2008267048B2 (en) Azapeptide derivatives
JP2025096427A (ja) 抗ウイルスプロドラッグ及びその製剤
JP7736929B2 (ja) Ｈｉｖウイルス感染症のための治療化合物
JP2022514214A5 (cg-RX-API-DMAC7.html)
CN105669751B (zh) 非环核苷酸磷酰胺类化合物及其盐的制备以及在抗病毒方面的应用
JP2010501584A5 (cg-RX-API-DMAC7.html)
JP2024540163A5 (cg-RX-API-DMAC7.html)
JPH08269006A (ja) 一酸化窒素合成酵素阻害作用を有するアニリン誘導体
JP2021534106A5 (cg-RX-API-DMAC7.html)
JP2024546946A5 (cg-RX-API-DMAC7.html)
KR20110013411A (ko) (ｆ-19)-표지된 ｌ-글루탐산 및 ｌ-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법
JP2025505200A5 (cg-RX-API-DMAC7.html)
JP2025501509A5 (cg-RX-API-DMAC7.html)
JP2023513794A5 (cg-RX-API-DMAC7.html)
PT98007A (pt) Processo para a preparacao de aminobenzodiazepinas e de composicoes farmaceuticas que as contem
JP2016532646A (ja) カテプシンシステインプロテアーゼ阻害剤
US20050187170A1 (en) Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
JP2024540161A5 (cg-RX-API-DMAC7.html)
JP2022522890A5 (cg-RX-API-DMAC7.html)
JP2024546943A5 (cg-RX-API-DMAC7.html)
US6812252B2 (en) Acylsulfonamide derivatives
US20130096092A1 (en) Thioether prodrug compositions as anti-hiv and anti-retroviral agents